Novanta (NASDAQ:NOVT) Releases FY 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 3.660-3.710 for the period, compared to the consensus EPS estimate of 3.690. The company issued revenue guidance of $1.1 billion, compared to the consensus revenue estimate of $1.1 billion. Novanta also updated its Q4 2026 guidance to 0.910-0.960 EPS.

Novanta Trading Up 8.0%

Novanta stock opened at $145.98 on Tuesday. Novanta has a 52 week low of $98.27 and a 52 week high of $176.38. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.79 and a current ratio of 4.57. The firm has a market capitalization of $5.52 billion, a price-to-earnings ratio of 41.73 and a beta of 1.71. The company has a 50 day moving average price of $142.25 and a 200 day moving average price of $142.59.

Novanta (NASDAQ:NOVT) last announced its earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.08. Novanta had a net margin of 6.00% and a return on equity of 10.83%. The company had revenue of $305.01 million for the quarter, compared to the consensus estimate of $301.02 million. During the same period in the previous year, the business earned $0.87 EPS. The company’s revenue was up 23.1% on a year-over-year basis. Research analysts forecast that Novanta will post 3.70 EPS for the current year.

Analysts Set New Price Targets

NOVT has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a report on Tuesday, October 13th. Zacks Research lowered Novanta from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Wall Street Zen raised Novanta from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Robert W. Baird set a $194.00 price objective on Novanta in a research report on Friday, August 7th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $194.00.

Novanta Company Profile

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software.

The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

Novanta was formerly known as GSI Group and adopted the Novanta name in 2016.